Anika Therapeutics reported $144K in Ordinary Share Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acceleron Pharma XLRN:US $ 0.06M 0M
Adamas Pharmaceuticals ADMS:US 50K 0
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Anika Therapeutics ANIK:US $ 0.14M 0M
Chemocentryx CCXI:US $ 0.07M 0M
Clovis Oncology CLVS:US $ 0.13M 0.01M
Dicerna Pharmaceuticals DRNA:US $ 0.01M 0M
Flexion Therapeutics FLXN:US $ 50K 0
Halozyme Therapeutics HALO:US $ 0.14M 0M
Heron Therapeutics HRTX:US $ 1.02M 0M
Insmed INSM:US $ 1.18M 32K
Integra Lifesciences IART:US $ 0.9M 0M
Intrexon XON:US $ 0M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Ligand Pharmaceuticals LGND:US $ 0.02M 0M
Macrogenics MGNX:US $ 0.61M 0.01M
Merit Medical Systems MMSI:US $ 633.95M 10.36M
Peregrine Pharmaceuticals PPHM:US $ 0.06M 0M
Rigel Pharmaceuticals RIGL:US $ 0.17M 0M
Sangamo Biosciences SGMO:US $ 1.46M 0M
Veracyte VCYT:US $ 0.07M 0M
Xencor XNCR:US $ 0.58M 0M
Zimmer Biomet Holdings Inc ZBH:US $ 3.1M 0